Novacyt: test approved in UK

(CercleFinance.com) - Novacyt, the international clinical diagnostics specialist, today announced that the PROmate (r) COVID-19 1G (q32) real-time assay has been approved in the UK under the provisions of the UK Medical Devices Safety Agency (CTDA) Regulation 2021.


The test is the second direct PCR test and the third product from the company to be added to the CTDA register of approved products.

The test is designed to detect a SARS-CoV-2 target gene in ORF1ab and, like all of the Company's direct PCR products, does not require complex manual or automated extraction solutions, significantly improving laboratory workflow and reducing costs, the company said.

Despite this, the share is currently down about 1.5% in mid-morning trading today.


Copyright (c) 2022 CercleFinance.com. All rights reserved.